GlobeNewswire
-
Vittoria Biotherapeutics to Present Phase 1 Results for Senza5 CART5 in T-Cell Lymphoma in an Oral Session and LampTAC Degrader Platform Data in a Poster Session at ASH 2026
17/11/2026 -
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications
17/11/2026 -
GATC Health and Hesperos Partner to Build FDA-Aligned NAMs Workflow That Aims to Cut Time and Cost of Preclinical Testing
17/11/2026 -
Conexeu Sciences Announces Early-Stage Development of W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, Fabricated Formats of Its Investigational CXU™ Platform
17/11/2026 -
TOMI Environmental Solutions Regains Compliance with Nasdaq Minimum Bid Price and Stockholders’ Equity Requirements
17/11/2026 -
Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
17/11/2026 -
Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member
17/11/2026 -
OXB confirms partnership with Aura Biosciences supporting Phase 3 development and future commercial supply of lead oncology candidate
17/11/2026 -
Libtayo® (cemiplimab) Approved in the European Union (EU) for Extended Dosing and Faster Infusion Times Across Skin, Lung and Cervical Cancer Indications
17/11/2026 -
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
17/11/2026 -
Smaller Travel Companies Can Prepare Customer Support for Travel Disruptions Before Holiday Travel Begins
17/11/2026 -
Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
17/11/2026 -
Noom Launches OpenRx, a New Peptide and Preventive Health Brand
17/11/2026 -
Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
17/11/2026 -
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
17/11/2026 -
Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study
17/11/2026 -
Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer
17/11/2026 -
Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
17/11/2026 -
Biocomposites welcomes new clinical pathway for local infection management in severe pressure ulcers
17/11/2026
Pages